Literature DB >> 16362637

The effect of psychostimulants on [3H]dopamine uptake and release in rat brain synaptic vesicles.

K Schwartz1, A Weizman, M Rehavi.   

Abstract

Amphetamine and its derivatives are psychostimulants active at the plasma membrane monoamine transporters. In the present study we assessed the interaction of parachloroamphetamine, D-amphetamine, fenfluramine and methylendioxymethamphetamine with brain vesicular monoamine transporter using purified rat striatal synaptic vesicles. All four psychostimulants inhibited vesicular [(3)H]dopamine uptake in a competitive and dose-dependent manner and had no effect on [(3)H]dihydrotetrabenazine binding. At higher concentrations the drugs enhanced [(3)H]dopamine vesicular efflux. Parachloroamphetamine was the most potent agent while methylendioxymethamphetamine was the weakest one. The vesicular activities may be relevant to their neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362637     DOI: 10.1007/s00702-005-0383-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  16 in total

1.  Studies on the mechanism of p-chloroamphetamine neurotoxicity.

Authors:  J E Sprague; M P Johnson; C J Schmidt; D E Nichols
Journal:  Biochem Pharmacol       Date:  1996-10-25       Impact factor: 5.858

Review 2.  Vesicular neurotransmitter transporters: from bacteria to humans.

Authors:  S Schuldiner; A Shirvan; M Linial
Journal:  Physiol Rev       Date:  1995-04       Impact factor: 37.312

3.  Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.

Authors:  J F Fischer; A K Cho
Journal:  J Pharmacol Exp Ther       Date:  1979-02       Impact factor: 4.030

4.  Conditions required for reserpine binding to the catecholamine transporter on chromaffin granule ghosts.

Authors:  J A Weaver; J D Deupree
Journal:  Eur J Pharmacol       Date:  1982-06-04       Impact factor: 4.432

5.  Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter.

Authors:  G Rudnick; S S Steiner-Mordoch; H Fishkes; Y Stern-Bach; S Schuldiner
Journal:  Biochemistry       Date:  1990-01-23       Impact factor: 3.162

6.  Dihydrotetrabenazine binding and monoamine uptake in mouse brain regions.

Authors:  D Scherman
Journal:  J Neurochem       Date:  1986-08       Impact factor: 5.372

7.  Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine.

Authors:  N Y Liang; C O Rutledge
Journal:  Biochem Pharmacol       Date:  1982-03-15       Impact factor: 5.858

8.  The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.

Authors:  G Rudnick; S C Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.

Authors:  M I Colado; A R Green
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

10.  Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.

Authors:  S Schuldiner; S Steiner-Mordoch; R Yelin; S C Wall; G Rudnick
Journal:  Mol Pharmacol       Date:  1993-12       Impact factor: 4.436

View more
  9 in total

1.  A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.

Authors:  Peter D Alexander; Kristina M Gicas; Taylor S Willi; Clara N Kim; Veronika Boyeva; Ric M Procyshyn; Geoff N Smith; Allen E Thornton; William J Panenka; Andrea A Jones; Fidel Vila-Rodriguez; Donna J Lang; G William MacEwan; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2017-02-11       Impact factor: 4.530

2.  Cocaine, but not amphetamine, short term treatment elevates the density of rat brain vesicular monoamine transporter 2.

Authors:  K Schwartz; R Nachman; M Yossifoff; R Sapir; A Weizman; M Rehavi
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

3.  Importance of Substrate-Coupled Proton Antiport by the Vesicular Monoamine Transporter in the Actions of Amphetamines in Drosophila Brain.

Authors:  Takato Hiranita; Zachary Freyberg
Journal:  J Alcohol Drug Depend       Date:  2016-12-16

Review 4.  Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry.

Authors:  Kandatege Wimalasena
Journal:  Med Res Rev       Date:  2010-02-04       Impact factor: 12.944

5.  Neuroprotective effects of various doses of topiramate against methylphenidate-induced oxidative stress and inflammation in isolated rat amygdala: the possible role of CREB/BDNF signaling pathway.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Reza Falak; Mansour Heidari; Mahshid Sharzad; Elham Kalantari
Journal:  J Neural Transm (Vienna)       Date:  2016-09-24       Impact factor: 3.575

6.  Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum.

Authors:  Andrea N Ortiz; Benjamin J Kurth; Gregory L Osterhaus; Michael A Johnson
Journal:  J Neurochem       Date:  2009-11-19       Impact factor: 5.372

Review 7.  Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.

Authors:  Jean Lud Cadet; Irina N Krasnova; Subramaniam Jayanthi; Johnalyn Lyles
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

8.  Preclinical Efficacy of Novel Vesicular Monoamine Transporter 2 Inhibitors as Antagonists of d-Methamphetamine Self-Administration in Rats.

Authors:  Takato Hiranita
Journal:  J Alcohol Drug Depend       Date:  2015-10-27

Review 9.  Natural Products in Modulating Methamphetamine-Induced Neuronal Apoptosis.

Authors:  Yiwei Zeng; Yunhui Chen; Su Zhang; Huan Ren; Jialin Xia; Mengnan Liu; Baozhi Shan; Yulan Ren
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.